nach oben

Head and Neck Pathology

Erschienen in:

15.03.2021 | Special Issue: Pediatric Pathology

Selected Topics in the Pathology of the Thyroid and Parathyroid Glands in Children and Adolescents

verfasst von: John A. Ozolek

Erschienen in: Head and Neck Pathology | Ausgabe 1/2021

Einloggen, um Zugang zu erhalten

Abstract

The goals of this chapter in keeping with the overall general themes of this special edition will be (1) to highlight aspects of development of the thyroid and parathyroid glands with particular focus on the role and contribution of the neural crest (or not) and how this may impact on the pathology that is seen, (2) to emphasize those lesions particularly more commonly arising in the pediatric population that actually generate specimens that the surgical pathologist would encounter, and (3) highlight more in depth specific lesions associated with heritable syndromes or specific gene mutations since the heritable syndromes tends to manifest in the pediatric age group. In this light, the other interesting areas of pediatric thyroid disease including medical thyroid diseases, congenital hypothyroidism, anatomic variants and aberrations of development that lead to structural anomalies will not be emphasized here.

Benard V (2018) NPCR and SEER Incidence—U.S. Cancer Statistics 2001–2016 Public Use Database Data Standards and Data Dictionary. Centers for Disease Control (pp. 33–48). https://www.cdc.gov/cancer/uscs/public-use/pdf/npcr-seer-public-use-database-data-dictionary-2001-2016-508.pdf

Qian ZJ, Jin MC, Meister KD, Megwalu UC. Pediatric Thyroid Cancer Incidence and Mortality Trends in the United States, 1973–2013. JAMA Otolaryngol Head Neck Surg. 2019;145(7):617–23. https://doi.org/10.1001/jamaoto.2019.0898.CrossRefPubMedPubMedCentral

Bernier MO, Withrow DR, Berrington de Gonzalez A, Lam CJK, Linet MS, Kitahara CM, et al. Trends in pediatric thyroid cancer incidence in the United States, 1998–2013. Cancer. 2019;125(14):2497–505. https://doi.org/10.1002/cncr.32125.CrossRefPubMedPubMedCentral

Vanderpump MP. The epidemiology of thyroid disease. Br Med Bull. 2011;99:39–51. https://doi.org/10.1093/bmb/ldr030.CrossRefPubMed

Paulson VA, Rudzinski ER, Hawkins DS. Thyroid cancer in the pediatric population. Genes (Basel). 2019. https://doi.org/10.3390/genes10090723.CrossRefPubMedPubMedCentral

Guille JT, Opoku-Boateng A, Thibeault SL, Chen H. Evaluation and management of the pediatric thyroid nodule. Oncologist. 2015;20(1):19–27. https://doi.org/10.1634/theoncologist.2014-0115.CrossRefPubMed

Hong HS, Lee EH, Jeong SH, Park J, Lee H. Ultrasonography of various thyroid diseases in children and adolescents: a pictorial essay. Korean J Radiol. 2015;16(2):419–29. https://doi.org/10.3348/kjr.2015.16.2.419.CrossRefPubMedPubMedCentral

Koch CA, Sarlis NJ. The spectrum of thyroid diseases in childhood and its evolution during transition to adulthood: natural history, diagnosis, differential diagnosis and management. J Endocrinol Invest. 2001;24(9):659–75. https://doi.org/10.1007/BF03343911.CrossRefPubMed

Nikiforov Y, Biddinger PW, Thompson LDR. Diagnostic pathology and molecular genetics of the thyroid. 2nd ed. Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins; 2012.

10.

Ozolek JA. Selective pathologies of the head and neck in children: a developmental perspective. Adv Anat Pathol. 2009;16(5):332–58. https://doi.org/10.1097/PAP.0b013e3181b50571.CrossRefPubMed

11.

Subramanyam P, Palaniswamy SS. Pictorial essay of developmental thyroid anomalies identified by Technetium thyroid scintigraphy. Indian J Nucl Med. 2015;30(4):323–7. https://doi.org/10.4103/0972-3919.159694.CrossRefPubMedPubMedCentral

12.

Nilsson M, Fagman H. Development of the thyroid gland. Development. 2017;144(12):2123–40. https://doi.org/10.1242/dev.145615.CrossRefPubMed

13.

Nilsson M, Williams D. On the origin of cells and derivation of thyroid cancer: C cell story revisited. Eur Thyroid J. 2016;5(2):79–93. https://doi.org/10.1159/000447333.CrossRefPubMedPubMedCentral

14.

Kameda Y, Nishimaki T, Chisaka O, Iseki S, Sucov HM. Expression of the epithelial marker E-cadherin by thyroid C cells and their precursors during murine development. J Histochem Cytochem. 2007;55(10):1075–88. https://doi.org/10.1369/jhc.7A7179.2007.CrossRefPubMed

15.

Bohnsack BL, Kahana A. Thyroid hormone and retinoic acid interact to regulate zebrafish craniofacial neural crest development. Dev Biol. 2013;373(2):300–9. https://doi.org/10.1016/j.ydbio.2012.11.005.CrossRefPubMed

16.

Gordon J. Hox genes in the pharyngeal region: how Hoxa3 controls early embryonic development of the pharyngeal organs. Int J Dev Biol. 2018;62(11–12):775–83. https://doi.org/10.1387/ijdb.180284jg.CrossRefPubMed

17.

Nagayama Y, Shimamura M, Mitsutake N. Cancer stem cells in the thyroid. Front Endocrinol (Lausanne). 2016;7:20. https://doi.org/10.3389/fendo.2016.00020.CrossRefPubMedPubMedCentral

18.

Scognamiglio T. C cell and follicular epithelial cell precursor lesions of the thyroid. Arch Pathol Lab Med. 2017;141(12):1646–52. https://doi.org/10.5858/arpa.2016-0399-RA.CrossRefPubMed

19.

Dupin E, Calloni G, Real C, Goncalves-Trentin A, Le Douarin NM. Neural crest progenitors and stem cells. C R Biol. 2007;330(6–7):521–9. https://doi.org/10.1016/j.crvi.2007.04.004.CrossRefPubMed

20.

Kameda Y. Cellular and molecular events on the development of mammalian thyroid C cells. Dev Dyn. 2016;245(3):323–41. https://doi.org/10.1002/dvdy.24377.CrossRefPubMed

21.

Lo CW, Cohen MF, Huang GY, Lazatin BO, Patel N, Sullivan R, et al. Cx43 gap junction gene expression and gap junctional communication in mouse neural crest cells. Dev Genet. 1997;20(2):119–32. https://doi.org/10.1002/(SICI)1520-6408(1997)20:2%3c119::AID-DVG5%3e3.0.CO;2-A.CrossRefPubMed

22.

Johansson E, Andersson L, Ornros J, Carlsson T, Ingeson-Carlsson C, Liang S, et al. Revising the embryonic origin of thyroid C cells in mice and humans. Development. 2015;142(20):3519–28. https://doi.org/10.1242/dev.126581.CrossRefPubMedPubMedCentral

23.

Chisaka O, Kameda Y. Hoxa3 regulates the proliferation and differentiation of the third pharyngeal arch mesenchyme in mice. Cell Tissue Res. 2005;320(1):77–89. https://doi.org/10.1007/s00441-004-1042-z.CrossRefPubMed

24.

Kameda Y, Arai Y, Nishimaki T, Chisaka O. The role of Hoxa3 gene in parathyroid gland organogenesis of the mouse. J Histochem Cytochem. 2004;52(5):641–51. https://doi.org/10.1177/002215540405200508.CrossRefPubMed

25.

Kameda Y, Nishimaki T, Miura M, Jiang SX, Guillemot F. Mash1 regulates the development of C cells in mouse thyroid glands. Dev Dyn. 2007;236(1):262–70. https://doi.org/10.1002/dvdy.21018.CrossRefPubMed

26.

Filis P, Hombach-Klonisch S, Ayotte P, Nagrath N, Soffientini U, Klonisch T, et al. Maternal smoking and high BMI disrupt thyroid gland development. BMC Med. 2018;16(1):194. https://doi.org/10.1186/s12916-018-1183-7.CrossRefPubMedPubMedCentral

27.

Jarzab B, Handkiewicz-Junak D. Differentiated thyroid cancer in children and adults: same or distinct disease? Hormones (Athens). 2007;6(3):200–9.PubMed

28.

Karapanou O, Tzanela M, Vlassopoulou B, Kanaka-Gantenbein C. Differentiated thyroid cancer in childhood: a literature update. Hormones (Athens). 2017;16(4):381–7. https://doi.org/10.14310/horm.2002.1758.CrossRefPubMed

29.

Leboulleux S, Baudin E, Hartl DW, Travagli JP, Schlumberger M. Follicular cell-derived thyroid cancer in children. Horm Res. 2005;63(3):145–51. https://doi.org/10.1159/000084717.CrossRefPubMed

30.

Francis GL, Waguespack SG, Bauer AJ, Angelos P, Benvenga S, Cerutti JM, et al. Management guidelines for children with thyroid nodules and differentiated thyroid cancer. Thyroid. 2015;25(7):716–59. https://doi.org/10.1089/thy.2014.0460.CrossRefPubMedPubMedCentral

31.

Santoro M, Carlomagno F. Central role of RET in thyroid cancer. Cold Spring Harb Perspect Biol. 2013;5(12):a009233. https://doi.org/10.1101/cshperspect.a009233.CrossRefPubMedPubMedCentral

32.

Pachnis V, Mankoo B, Costantini F. Expression of the c-ret proto-oncogene during mouse embryogenesis. Development. 1993;119(4):1005–17.PubMed

33.

Khatami F, Tavangar SM. Multiple endocrine neoplasia syndromes from genetic and epigenetic perspectives. Biomark Insights. 2018;13:1177271918785129. https://doi.org/10.1177/1177271918785129.CrossRefPubMedPubMedCentral

34.

Marini F, Falchetti A, Del Monte F, Carbonell Sala S, Gozzini A, Luzi E, et al. Multiple endocrine neoplasia type 1. Orphanet J Rare Dis. 2006;1:38. https://doi.org/10.1186/1750-1172-1-38.CrossRefPubMedPubMedCentral

35.

Martucciello G, Lerone M, Bricco L, Tonini GP, Lombardi L, Del Rossi CG, et al. Multiple endocrine neoplasias type 2B and RET proto-oncogene. Ital J Pediatr. 2012;38:9. https://doi.org/10.1186/1824-7288-38-9.CrossRefPubMedPubMedCentral

36.

Millar S, Bradley L, Donnelly DE, Carson D, Morrison PJ. Familial pediatric endocrine tumors. Oncologist. 2011;16(10):1388–96. https://doi.org/10.1634/theoncologist.2011-0120.CrossRefPubMedPubMedCentral

37.

Zirilli G, Salzano G, Corica D, Pajno GB, Mignosa C, Pepe G, et al. Thyrotropin serum levels and coexistence with Hashimoto’s thyroiditis as predictors of malignancy in children with thyroid nodules. Ital J Pediatr. 2019;45(1):96. https://doi.org/10.1186/s13052-019-0693-z.CrossRefPubMedPubMedCentral

38.

Hincza K, Kowalik A, Kowalska A. Current knowledge of germline genetic risk factors for the development of non-medullary thyroid cancer. Genes (Basel). 2019. https://doi.org/10.3390/genes10070482.CrossRefPubMedPubMedCentral

39.

Wang H, Mehrad M, Ely KA, Liang J, Solorzano CC, Neblett WW 3rd, et al. Incidence and malignancy rates of indeterminate pediatric thyroid nodules. Cancer Cytopathol. 2019;127(4):231–9. https://doi.org/10.1002/cncy.22104.CrossRefPubMed

40.

Picarsic JL, Buryk MA, Ozolek J, Ranganathan S, Monaco SE, Simons JP, et al. Molecular characterization of sporadic pediatric thyroid carcinoma with the DNA/RNA ThyroSeq v2 next-generation sequencing assay. Pediatr Dev Pathol. 2016;19(2):115–22. https://doi.org/10.2350/15-07-1667-OA.1.CrossRefPubMed

41.

Geng J, Wang H, Liu Y, Tai J, Jin Y, Zhang J, et al. Correlation between BRAF (V600E) mutation and clinicopathological features in pediatric papillary thyroid carcinoma. Sci China Life Sci. 2017;60(7):729–38. https://doi.org/10.1007/s11427-017-9083-8.CrossRefPubMed

42.

Bertherat J. Carney complex (CNC). Orphanet J Rare Dis. 2006;1:21. https://doi.org/10.1186/1750-1172-1-21.CrossRefPubMedPubMedCentral

43.

Dinarvand P, Davaro EP, Doan JV, Ising ME, Evans NR, Phillips NJ, et al. Familial adenomatous polyposis syndrome: an update and review of extraintestinal manifestations. Arch Pathol Lab Med. 2019;143(11):1382–98. https://doi.org/10.5858/arpa.2018-0570-RA.CrossRefPubMed

44.

Eng C, Peacocke M. PTEN and inherited hamartoma-cancer syndromes. Nat Genet. 1998;19(3):223. https://doi.org/10.1038/897.CrossRefPubMed

45.

Garofola C, Jamal Z, Gross GP. Cowden Disease (Multiple Hamartoma Syndrome). StatPearls. Treasure Island (FL)2020.

46.

Pilarski R. PTEN hamartoma tumor syndrome: a clinical overview. Cancers (Basel). 2019. https://doi.org/10.3390/cancers11060844.CrossRefPubMedPubMedCentral

47.

Schultz KAP, Rednam SP, Kamihara J, Doros L, Achatz MI, Wasserman JD, et al. PTEN, DICER1, FH, and their associated tumor susceptibility syndromes: clinical features, genetics, and surveillance recommendations in childhood. Clin Cancer Res. 2017;23(12):e76–82. https://doi.org/10.1158/1078-0432.CCR-17-0629.CrossRefPubMed

48.

Lloyd RV, Osamura RY, Klöppel Gn, Rosai J, World Health O, International Agency for Research on C. WHO classification of tumours of endocrine organs. 2017

49.

Spinelli C, Strambi S, Bakkar S, Nosiglia A, Elia G, Bertocchini A, et al. Surgical management of diffuse sclerosing variant of papillary thyroid carcinoma: experience in 25 patients. World J Surg. 2020;44(1):155–62. https://doi.org/10.1007/s00268-019-05230-5.CrossRefPubMed

50.

Low S, Sakai Y, Hoshino H, Hirokawa M, Kawashima H, Higuchi K, et al. High endothelial venule-like vessels and lymphocyte recruitment in diffuse sclerosing variant of papillary thyroid carcinoma. Pathology. 2016;48(7):666–74. https://doi.org/10.1016/j.pathol.2016.08.002.CrossRefPubMed

51.

Joung JY, Kim TH, Jeong DJ, Park SM, Cho YY, Jang HW, et al. Diffuse sclerosing variant of papillary thyroid carcinoma: major genetic alterations and prognostic implications. Histopathology. 2016;69(1):45–53. https://doi.org/10.1111/his.12902.CrossRefPubMed

52.

Kobayashi K, Fujimoto T, Ota H, Hirokawa M, Yabuta T, Masuoka H, et al. Calcifications in thyroid tumors on ultrasonography: calcification types and relationship with histopathological type. Ultrasound Int Open. 2018;4(2):E45–51. https://doi.org/10.1055/a-0591-6070.CrossRefPubMedPubMedCentral

53.

Xue N, Xu Y, Huang P, Zhang S, Wang H, Yu F. Shear wave elastography diagnosis of the diffuse sclerosing variant of papillary thyroid carcinoma: a case report. Mol Clin Oncol. 2016;5(2):333–6. https://doi.org/10.3892/mco.2016.932.CrossRefPubMedPubMedCentral

54.

Andriescu EC, Caruntu ID, Giusca SE, Lozneanu L, Ciobanu Apostol DG. Prognostic significance of cell-adhesion molecules in histological variants of papillary thyroid carcinoma. Rom J Morphol Embryol. 2018;59(3):721–7.PubMed

55.

Feng J, Shen F, Cai W, Gan X, Deng X, Xu B. Survival of aggressive variants of papillary thyroid carcinoma in patients under 55 years old: a SEER population-based retrospective analysis. Endocrine. 2018;61(3):499–505. https://doi.org/10.1007/s12020-018-1644-y.CrossRefPubMed

56.

Holoubek SA, Yan H, Khokar AH, Kuchta KM, Winchester DJ, Prinz RA, et al. Aggressive variants of papillary thyroid microcarcinoma are associated with high-risk features, but not decreased survival. Surgery. 2020;167(1):19–27. https://doi.org/10.1016/j.surg.2019.03.030.CrossRefPubMed

57.

Limberg J, Ullmann TM, Stefanova D, Buicko JL, Finnerty BM, Zarnegar R, et al. Does aggressive variant histology without invasive features predict overall survival in papillary thyroid cancer?: A national cancer database analysis. Ann Surg. 2019. https://doi.org/10.1097/SLA.0000000000003632.CrossRefPubMed

58.

Malandrino P, Russo M, Regalbuto C, Pellegriti G, Moleti M, Caff A, et al. Outcome of the diffuse sclerosing variant of papillary thyroid cancer: a meta-analysis. Thyroid. 2016;26(9):1285–92. https://doi.org/10.1089/thy.2016.0168.CrossRefPubMed

59.

Russo M, Malandrino P, Moleti M, Vermiglio F, Violi MA, Marturano I, et al. Tall cell and diffuse sclerosing variants of papillary thyroid cancer: outcome and predicting value of risk stratification methods. J Endocrinol Invest. 2017;40(11):1235–41. https://doi.org/10.1007/s40618-017-0688-9.CrossRefPubMed

60.

Nieminen TT, Walker CJ, Olkinuora A, Genutis LK, O’Malley M, Wakely PE, et al. Thyroid carcinomas that occur in familial adenomatous polyposis patients recurrently harbor somatic variants in APC, BRAF, and KTM2D. Thyroid. 2020;30(3):380–8. https://doi.org/10.1089/thy.2019.0561.CrossRefPubMedPubMedCentral

61.

Akaishi J, Kondo T, Sugino K, Ogimi Y, Masaki C, Hames KY, et al. Cribriform-morular variant of papillary thyroid carcinoma: clinical and pathological features of 30 cases. World J Surg. 2018;42(11):3616–23. https://doi.org/10.1007/s00268-018-4644-4.CrossRefPubMed

62.

Park J, Kim JW, Park H, Park SY, Kim TH, Kim SW, et al. Multifocality in a patient with cribriform-morular variant of papillary thyroid carcinoma is an important clue for the diagnosis of familial adenomatous polyposis. Thyroid. 2019;29(11):1606–14. https://doi.org/10.1089/thy.2019.0261.CrossRefPubMed

63.

Aydemirli MD, van der Tuin K, Hes FJ, van den Ouweland AMW, van Wezel T, Kapiteijn E, et al. A unique case of two somatic APC mutations in an early onset cribriform-morular variant of papillary thyroid carcinoma and overview of the literature. Fam Cancer. 2020;19(1):15–21. https://doi.org/10.1007/s10689-019-00146-4.CrossRefPubMed

64.

Brehar AC, Terzea DC, Ioachim DL, Procopiuc C, Brehar FM, Bulgar AC, et al. Cribriform-morular variant of papillary thyroid carcinoma at pediatric age - case report and review of the literature. Rom J Morphol Embryol. 2016;57(2):531–7.PubMed

65.

Mohindra S, Sakr H, Sturgis C, Chute DJ. LEF-1 is a sensitive marker of cribriform morular variant of papillary thyroid carcinoma. Head Neck Pathol. 2018;12(4):455–62. https://doi.org/10.1007/s12105-017-0873-3.CrossRefPubMed

66.

Hirokawa M, Matsuda K, Kudo T, Higuchi M, Suzuki A, Takada N, et al. Cribriform-morular variant of papillary thyroid carcinoma shows high Ki-67 labeling indices, despite its excellent prognosis. Pathobiology. 2019;86(5–6):248–53. https://doi.org/10.1159/000501097.CrossRefPubMed

67.

Perrier ND, van Heerden JA, Goellner JR, Williams ED, Gharib H, Marchesa P et al. Thyroid cancer in patients with familial adenomatous polyposis. World J Surg. 1998;22(7):738–42; discussion 43. doi:https://doi.org/10.1007/s002689900462.

68.

Tsuji H, Yasuoka H, Nakamura Y, Hirokawa M, Hiroshima T, Sakamaki Y, et al. Aggressive cribriform-morular variant of papillary thyroid carcinoma: report of an unusual case with pulmonary metastasis displaying poorly differentiated features. Pathol Int. 2018;68(12):700–5. https://doi.org/10.1111/pin.12728.CrossRefPubMed

69.

Ito Y, Ishikawa H, Kihara M, Hirokawa M, Kiyota N, Kasahara T, et al. Control of lung metastases and colon polyposis with lenvatinib therapy in a patient with Cribriform-Morular variant of papillary thyroid carcinoma and an APC gene mutation: a case study. Thyroid. 2019;29(10):1511–7. https://doi.org/10.1089/thy.2019.0121.CrossRefPubMed

70.

Laforga JB, Pedro T, Gasent JM. Pulmonary metastasis of cribriform-morular variant of thyroid carcinoma mimicking primary adenocarcinoma of the lung: a potential pitfall. Diagn Cytopathol. 2020;48(1):78–81. https://doi.org/10.1002/dc.24312.CrossRefPubMed

71.

Eng C. PTEN Hamartoma Tumor Syndrome. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K et al., editors. GeneReviews((R)). Seattle (WA)1993.

72.

Tan MH, Eng C. RE: Cowden syndrome and PTEN hamartoma tumor syndrome: systematic review and revised diagnostic criteria. J Natl Cancer Inst. 2014;106(6):130. https://doi.org/10.1093/jnci/dju130.CrossRef

73.

Yu W, Ni Y, Saji M, Ringel MD, Jaini R, Eng C. Cowden syndrome-associated germline succinate dehydrogenase complex subunit D (SDHD) variants cause PTEN-mediated down-regulation of autophagy in thyroid cancer cells. Hum Mol Genet. 2017;26(7):1365–75. https://doi.org/10.1093/hmg/ddx037.CrossRefPubMedPubMedCentral

74.

Eissing M, Ripken L, Schreibelt G, Westdorp H, Ligtenberg M, Netea-Maier R, et al. PTEN hamartoma tumor syndrome and immune dysregulation. Transl Oncol. 2019;12(2):361–7. https://doi.org/10.1016/j.tranon.2018.11.003.CrossRefPubMed

75.

Tosur M, Brandt ML, Athanassaki ID, Rednam SP. Considerations for total thyroidectomy in an adolescent with PTEN mutation. Ther Adv Endocrinol Metab. 2018;9(9):299–301. https://doi.org/10.1177/2042018818784517.CrossRefPubMedPubMedCentral

76.

Cho U, Mete O, Kim MH, Bae JS, Jung CK. Molecular correlates and rate of lymph node metastasis of non-invasive follicular thyroid neoplasm with papillary-like nuclear features and invasive follicular variant papillary thyroid carcinoma: the impact of rigid criteria to distinguish non-invasive follicular thyroid neoplasm with papillary-like nuclear features. Mod Pathol. 2017;30(6):810–25. https://doi.org/10.1038/modpathol.2017.9.CrossRefPubMed

77.

Nikiforov YE, Seethala RR, Tallini G, Baloch ZW, Basolo F, Thompson LD, et al. Nomenclature revision for encapsulated follicular variant of papillary thyroid carcinoma: a paradigm shift to reduce overtreatment of indolent tumors. JAMA Oncol. 2016;2(8):1023–9. https://doi.org/10.1001/jamaoncol.2016.0386.CrossRefPubMedPubMedCentral

78.

Thompson LD. Ninety-four cases of encapsulated follicular variant of papillary thyroid carcinoma: a name change to Noninvasive Follicular Thyroid Neoplasm with Papillary-like Nuclear Features would help prevent overtreatment. Mod Pathol. 2016;29(7):698–707. https://doi.org/10.1038/modpathol.2016.65.CrossRefPubMed

79.

Rossi ED, Mehrotra S, Kilic AI, Toslak IE, Lim-Dunham J, Martini M, et al. Noninvasive follicular thyroid neoplasm with papillary-like nuclear features in the pediatric age group. Cancer Cytopathol. 2018;126(1):27–35. https://doi.org/10.1002/cncy.21933.CrossRefPubMed

80.

Mariani RA, Kadakia R, Arva NC. Noninvasive encapsulated follicular variant of papillary thyroid carcinoma: Should it also be reclassified in children? Pediatr Blood Cancer. 2018;65(6):e26966. https://doi.org/10.1002/pbc.26966.CrossRefPubMed

81.

Wang H, Correa H, Sanders M, Neblett WW, Liang J. Noninvasive follicular thyroid neoplasm with papillary-like nuclear features in children: an institutional experience and literature review. Pediatr Dev Pathol. 2020;23(2):121–6. https://doi.org/10.1177/1093526619866584.CrossRefPubMed

82.

Seethala RR, Baloch ZW, Barletta JA, Khanafshar E, Mete O, Sadow PM, et al. Noninvasive follicular thyroid neoplasm with papillary-like nuclear features: a review for pathologists. Mod Pathol. 2018;31(1):39–55. https://doi.org/10.1038/modpathol.2017.130.CrossRefPubMed

83.

Thomas CM, Asa SL, Ezzat S, Sawka AM, Goldstein D. Diagnosis and pathologic characteristics of medullary thyroid carcinoma-review of current guidelines. Curr Oncol. 2019;26(5):338–44. https://doi.org/10.3747/co.26.5539.CrossRefPubMedPubMedCentral

84.

Nelkin B. Recent advances in the biology and therapy of medullary thyroid carcinoma. Res. 2017;6:2184. https://doi.org/10.12688/f1000research.12645.1.CrossRef

85.

Zhao Z, Yin XD, Zhang XH, Li ZW, Wang DW. Comparison of pediatric and adult medullary thyroid carcinoma based on SEER program. Sci Rep. 2020;10(1):13310. https://doi.org/10.1038/s41598-020-70439-7.CrossRefPubMedPubMedCentral

86.

Wells SA Jr, Asa SL, Dralle H, Elisei R, Evans DB, Gagel RF, et al. Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma. Thyroid. 2015;25(6):567–610. https://doi.org/10.1089/thy.2014.0335.CrossRefPubMedPubMedCentral

87.

Cai S, Deng H, Chen Y, Wu X, Guan X. Treatment of medullary thyroid carcinoma with apatinib: a case report and literature review. Med (Baltimore). 2017;96(50):e8704. https://doi.org/10.1097/MD.0000000000008704.CrossRef

88.

Ozaki T, Nagashima K, Kusakabe T, Kakudo K, Kimura S. Development of thyroid gland and ultimobranchial body cyst is independent of p63. Lab Invest. 2011;91(1):138–46. https://doi.org/10.1038/labinvest.2010.137.CrossRefPubMed

89.

Preto A, Cameselle-Teijeiro J, Moldes-Boullosa J, Soares P, Cameselle-Teijeiro JF, Silva P, et al. Telomerase expression and proliferative activity suggest a stem cell role for thyroid solid cell nests. Mod Pathol. 2004;17(7):819–26. https://doi.org/10.1038/modpathol.3800124.CrossRefPubMed

90.

Rios Moreno MJ, Galera-Ruiz H, De Miguel M, Lopez MI, Illanes M, Galera-Davidson H. Inmunohistochemical profile of solid cell nest of thyroid gland. Endocr Pathol. 2011;22(1):35–9. https://doi.org/10.1007/s12022-010-9145-4.CrossRefPubMedPubMedCentral

91.

de Graaf P, van der Linde EM, Rosier P, Izeta A, Sievert KD, Bosch J, et al. Systematic review to compare urothelium differentiation with urethral epithelium differentiation in fetal development, as a basis for tissue engineering of the Male Urethra. Tissue Eng Part B. 2017;23(3):257–67. https://doi.org/10.1089/ten.TEB.2016.0352.CrossRef

92.

Hazard JB. The C cells (parafollicular cells) of the thyroid gland and medullary thyroid carcinoma. A Rev Am J Pathol. 1977;88(1):213–50.

93.

Wenig BM. Atlas of Head and Neck Pathology. Elsevier Health Sciences; 2015.

94.

<C CELLS AJP-1981.pdf>.

95.

Burke JF, Chen H, Gosain A. Parathyroid conditions in childhood. Semin Pediatr Surg. 2014;23(2):66–70. https://doi.org/10.1053/j.sempedsurg.2014.03.003.CrossRefPubMedPubMedCentral

96.

Peissig K, Condie BG, Manley NR. Embryology of the parathyroid glands. Endocrinol Metab Clin North Am. 2018;47(4):733–42. https://doi.org/10.1016/j.ecl.2018.07.002.CrossRefPubMedPubMedCentral

97.

Gordon RJ, Levine MA. Genetic disorders of parathyroid development and function. Endocrinol Metab Clin North Am. 2018;47(4):809–23. https://doi.org/10.1016/j.ecl.2018.07.007.CrossRefPubMedPubMedCentral

98.

Stokes VJ, Nielsen MF, Hannan FM, Thakker RV. Hypercalcemic disorders in children. J Bone Miner Res. 2017;32(11):2157–70. https://doi.org/10.1002/jbmr.3296.CrossRefPubMedPubMedCentral

99.

Black BK, Ackerman LV. Tumors of the parathyroid; a review of twenty-three cases. Cancer. 1950;3(3):415–44. https://doi.org/10.1002/1097-0142(1950)3:3%3c415::aid-cncr2820030304%3e3.0.co;2-#.CrossRefPubMed

100.

Busaidy NL, Jimenez C, Habra MA, Schultz PN, El-Naggar AK, Clayman GL, et al. Parathyroid carcinoma: a 22-year experience. Head Neck. 2004;26(8):716–26. https://doi.org/10.1002/hed.20049.CrossRefPubMed

101.

Fiedler AG, Rossi C, Gingalewski CA. Parathyroid carcinoma in a child: an unusual case of an ectopically located malignant parathyroid gland with tumor invading the thymus. J Pediatr Surg. 2009;44(8):1649–52. https://doi.org/10.1016/j.jpedsurg.2009.04.024.CrossRefPubMed

102.

Fujimoto Y, Obara T, Ito Y, Kanazawa K, Aiyoshi Y, Nobori M. Surgical treatment of ten cases of parathyroid carcinoma: importance of an initial en bloc tumor resection. World J Surg. 1984;8(3):392–400. https://doi.org/10.1007/BF01655086.CrossRefPubMed

103.

Hamill J, Maoate K, Beasley SW, Corbett R, Evans J. Familial parathyroid carcinoma in a child. J Paediatr Child Health. 2002;38(3):314–7. https://doi.org/10.1046/j.1440-1754.2002.00802.x.CrossRefPubMed

104.

Herrera-Hernandez AA, Aranda-Valderrama P, Diaz-Perez JA, Herrera LP. Intrathyroidal parathyroid carcinoma in a pediatric patient. Pediatr Surg Int. 2011;27(12):1361–5. https://doi.org/10.1007/s00383-011-2904-6.CrossRefPubMed

105.

Kim HK, Oh YL, Kim SH, Lee DY, Kang HC, Lee JI, et al. Parafibromin immunohistochemical staining to differentiate parathyroid carcinoma from parathyroid adenoma. Head Neck. 2012;34(2):201–6. https://doi.org/10.1002/hed.21716.CrossRefPubMed

106.

Korpi-Hyovalti E, Cranston T, Ryhanen E, Arola J, Aittomaki K, Sane T, et al. CDC73 intragenic deletion in familial primary hyperparathyroidism associated with parathyroid carcinoma. J Clin Endocrinol Metab. 2014;99(9):3044–8. https://doi.org/10.1210/jc.2014-1481.CrossRefPubMedPubMedCentral

107.

McHenry CR, Rosen IB, Walfish PG, Cooter N. Parathyroid crisis of unusual features in a child. Cancer. 1993;71(5):1923–7. https://doi.org/10.1002/1097-0142(19930301)71:5%3c1923::aid-cncr2820710531%3e3.0.co;2-v.CrossRefPubMed

108.

Meier DE, Snyder WH 3rd, Dickson BA, Margraf LR, Guzzetta PC Jr. Parathyroid carcinoma in a child. J Pediatr Surg. 1999;34(4):606–8. https://doi.org/10.1016/s0022-3468(99)90084-2.CrossRefPubMed

109.

Niramitmahapanya S, Deerochanawong C, Sarinnapakorn V, Sunthornthepvarakul T, Pingsuthiwong S, Athipan P, et al. Somatic HRPT2 mutation (Arg234X) of parathyroid carcinoma associated with slipped capital femoral epiphysis: a first case report. J Med Assoc Thai. 2016;99(Suppl 2):S201–5.PubMed

110.

Rahman MM, Karim SS, Joarder AI, Mubin S, Abir MM, Morshed MS. Parathyroid carcinoma in a 10 years old female child. Mymensingh Med J. 2015;24(3):619–23.PubMed

111.

Righi A, Dimosthenous K, Mize J. Mediastinal parathyroid carcinoma with tumor implants in a child: a unique occurrence. Int J Surg Pathol. 2008;16(4):458–60. https://doi.org/10.1177/1066896908315821.CrossRefPubMed

112.

Schantz A, Castleman B. Parathyroid carcinoma: A study of 70 cases. Cancer. 1973;31(3):600–5.CrossRef

113.

Serrano-Gonzalez M, Shay S, Austin J, Maceri DR, Pitukcheewanont P. A germline mutation of HRPT2/CDC73 (70 G>T) in an adolescent female with parathyroid carcinoma: first case report and a review of the literature. J Pediatr Endocrinol Metab. 2016;29(9):1005–12. https://doi.org/10.1515/jpem-2016-0109.CrossRefPubMed

114.

Vinodh M, Rajeshwari A. Parathyroid carcinoma presenting as genu valgum. Indian Pediatr. 2012;49(2):156. https://doi.org/10.1007/s13312-012-0014-8.CrossRefPubMed

115.

Young TO, Saltzstein EC, Boman DA. Parathyroid carcinoma in a child: unusual presentation with seizures. J Pediatr Surg. 1984;19(2):194–6. https://doi.org/10.1016/s0022-3468(84)80448-0.CrossRefPubMed

116.

Zivaljevic VR, Jovanovic MD, Djordjevic MS, Diklic AD, Paunovic IR. Case report of parathyroid carcinoma in a pediatric patient. Int J Pediatr Otorhinolaryngol. 2019;124:120–3. https://doi.org/10.1016/j.ijporl.2019.06.003.CrossRefPubMed

117.

Kelly TG, Shattuck TM, Reyes-Mugica M, Stewart AF, Simonds WF, Udelsman R, et al. Surveillance for early detection of aggressive parathyroid disease: carcinoma and atypical adenoma in familial isolated hyperparathyroidism associated with a germline HRPT2 mutation. J Bone Miner Res. 2006;21(10):1666–71. https://doi.org/10.1359/jbmr.060702.CrossRefPubMed

118.

Rosai J, DeLellis R, Carcangiu M, Frable W, Tallina G. Tumors of the thyroid and parathyroid glands. 4th ed. AFIP Atlas of Tumor Pathology. ARP Press; 2014

Titel: Selected Topics in the Pathology of the Thyroid and Parathyroid Glands in Children and Adolescents
verfasst von: John A. Ozolek
Publikationsdatum: 15.03.2021
Verlag: Springer US
Erschienen in: Head and Neck Pathology / Ausgabe 1/2021
Elektronische ISSN: 1936-0568
DOI: https://doi.org/10.1007/s12105-020-01274-5

Neu im Fachgebiet Pathologie

01.04.2024 | Forensische Traumatologie | CME

Springer Medizin

Selected Topics in the Pathology of the Thyroid and Parathyroid Glands in Children and Adolescents

Abstract

Neu im Fachgebiet Pathologie

Theoretische Grundlagen von Explosionen und Explosionsverletzungen

Auswirkungen vorgeschalteter Laborprozesse auf die Digitalisierung histologischer Schnittpräparate

Knochenmarkhistologie bei Zytopenien

Herausforderungen der Automation bei der quantitativen Auswertung von Leberbiopsien

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2021

YAP1-MAML2-Rearranged Poroid Squamous Cell Carcinoma (Squamoid Porocarcinoma) Presenting as a Primary Parotid Gland Tumor

Human Tissue Kallikreins in Polymorphous Adenocarcinoma: A Polymerase Chain Reaction and Immunohistochemical Study

The Most Common Mistake in Laryngeal Pathology and How to Avoid it

Expanding Awareness of the Distribution and Biologic Potential of Ectomesenchymal Chondromyxoid Tumor

Does Mixed Neuroendocrine-Nonneuroendocrine Neoplasm (MiNEN) of the Parathyroid Gland Exist? First Description of a Possible Case

Gingival Swelling as the Initial Manifestation of Granulomatosis with Polyangiitis

Neu im Fachgebiet Pathologie

Theoretische Grundlagen von Explosionen und Explosionsverletzungen

Auswirkungen vorgeschalteter Laborprozesse auf die Digitalisierung histologischer Schnittpräparate

Knochenmarkhistologie bei Zytopenien

Herausforderungen der Automation bei der quantitativen Auswertung von Leberbiopsien